In the study, we concentrated on our hypothesis, which is based on the speculation that adropin may be a promising biomarker, allowing us to identify patients with HF who show a tendency of declining levels of NT-proBNP in their peripheral blood. The gene discussed is ENHO; the disease is hydrops fetalis.